Protocol T 2-Year Data Released

Three antivascular endothelial growth factor (anti-VEGF) agents evaluated in the Diabetic Retinopathy Clinical Research Network Protocol T trial were effective in treating diabetic macular edema (DME) at 2 years, according to a...